Last Posted: Jun 23, 2020
- Association Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer Disease
NS Raghavan et al, JAMA Neurology, June 22, 2020 - Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease
S Dujardin et al, Nature Medicine, June 22, 2020 - Pharmacogenetic considerations when prescribing cholinesterase inhibitors for the treatment of Alzheimer's disease.
Cacabelos Ramón et al. Expert opinion on drug metabolism & toxicology 2020 Jun - Automated MRI-Based Deep Learning Model for Detection of Alzheimer's Disease Process.
Feng Wei et al. International journal of neural systems 2020 Jun 30(6) 2050032 - Genotype concordance and polygenic risk score estimation across consumer genetic testing data.
Batra Prag et al. Annals of human genetics 2020 May - ARTIFICIAL INTELLIGENCE AND NEUROPSYCHOLOGICAL MEASURES: THE CASE OF ALZHEIMER'S DISEASE.
Battista Petronilla et al. Neuroscience and biobehavioral reviews 2020 May - Application of Next-Generation Sequencing in Neurodegenerative Diseases: Opportunities and Challenges.
Shademan Behrouz et al. Neuromolecular medicine 2020 May - Classification of Alzheimer's Disease with Respect to Physiological Aging with Innovative EEG Biomarkers in a Machine Learning Implementation.
Vecchio Fabrizio et al. Journal of Alzheimer's disease : JAD 2020 May - Convolutional neural networks for classification of Alzheimer's disease: Overview and reproducible evaluation.
Wen Junhao et al. Medical image analysis 2020 May 63101694 - Deep Learning based Mild Cognitive Impairment Diagnosis Using Structure MR Images.
Jiang Jingwan et al. Neuroscience letters 2020 May 134971
No hay comentarios:
Publicar un comentario